Bills · 2021-2022 Regular Session
Relating to: diabetes medication pilot project and granting rule-making authority. (FE)
Disease Drugs Insurance — Commissioner office of Pharmacy Physical therapy
- Introduced, stopped here
- Passes Senate, not reached
- Passes Assembly, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill directs the Office of the Commissioner of Insurance to develop a pilot
project under which a pharmacy benefit manager and pharmaceutical manufacturer
are directed to create a value-based, sole-source arrangement to reduce the costs of
prescription diabetes medication. The bill allows OCI to promulgate rules to
implement the pilot project.
What it would cost
Fiscal estimates filed by state agencies, as official PDFs
Sponsors
Introduced by: Agard (D) , Carpenter (D) , Erpenbach (D) , Johnson (D) , Larson (D) , Pfaff (D) , Roys (D)
23 cosponsors
Anderson (D) , Baldeh (D) , Cabrera (D) , Conley (D) , Considine (D) , Doyle (D) , Emerson (D) , Hebl (D) , Hesselbein (D) , Hong (D) , Milroy (D) , Neubauer (D) , Ohnstad (D) , Pope (D) , S. Rodriguez (D) , Shankland (D) , Shelton (D) , Snodgrass (D) , Spreitzer (D) , Stubbs (D) , Subeck (D) , Vining (D) , Vruwink (D)
Full history
- Sep 2, 2021 · Senate
Introduced by Senators Erpenbach, Johnson, Agard, Carpenter, Larson, Pfaff and Roys; cosponsored by Representatives Subeck, Vining, Anderson, Baldeh, Cabrera, Conley, Considine, Doyle, Emerson, Hebl, Hesselbein, Hong, Milroy, Neubauer, Ohnstad, Pope, S. Rodriguez, Shankland, Shelton, Snodgrass, Spreitzer, Stubbs and Vruwink
- Sep 2, 2021 · Senate
Read first time and referred to Committee on Insurance, Licensing and Forestry
- Sep 29, 2021 · Senate
Fiscal estimate received
- Mar 15, 2022 · Senate
Failed to pass pursuant to Senate Joint Resolution 1